While the allogeneic vs autologous debate continues in the cell therapy field, research on in vivo therapies is drawing ...

The ability to perceive the bitter taste is thought to have evolved as a protective mechanism, signaling the presence of ...

ER+/PR+ breast cancer, common and hormone-responsive, offers a better prognosis and is key in treatment research advancements ...

Frequent mutations of SARS-CoV-2 have reduced the effectiveness of vaccines, highlighting the need for mutation-resistant ...

Each cell in your body relies on precise communication with other cells to function properly. At the center of this process ...

A first-of-a-kind therapy that inhibits a population of T cells proved active and safe in a phase 3 trial for moderate to severe atopic dermatitis, introducing a novel mechanism to treat ...

An in-depth analysis of ER+ breast cancer, focusing on its prevalence, molecular biology, current treatments, and emerging ...